MED stock

MEDIFAST INC (MED) support and resistance · rev $602.5M

MEDIFAST INC (MED) is a personal services company listed on NYSE.

This page maps MEDIFAST INC (MED) support and resistance from cached range and valuation — not a live tape and not a trade alert.

Latest reported MED revenue for 2024-12-31 was $602.5M. Net income was $2.1M. Revenue was down 43.8% from 2023-12-31 to 2024-12-31. MED currently screens at market cap $125.3M.

MED currently screens at market cap $125.3M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.

A new MED 8-K or 10-Q can move the levels that matter more than a drawing on a chart.

Not investment advice. Use the MED quote page for the session range and the stock page for the full model.

Not investment advice.

Full MED analysis